From: VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis
 | Genotype | NF PsA patients | Controls |
---|---|---|---|
VEGF+936 | CC | 200/258 (77.5%) | 100/146 (68.5%) |
rs3025039 | CT | 56/258 (21.7%) | 43/146 (29.5%) |
 | TT | 2/258 (0.8%) | 3/146 (2.0%) |
Allele Freq (T) | Â | 11.6% | 16.8% |
VEGF-1154 | GG | 69/257 (26.8%) | 35/147 (23.8%) |
rs1570360 | GA | 121/257 (47.1%) | 69/147 (46.9%) |
 | AA | 67/257 (26.1%) | 43/147 (29.3%) |
Allele Freq (A) | Â | 49.6% | 52.7% |
VEGF-2578 | AA | 68/257 (26.5%) | 45/150 (30.0%) |
rs699947 | AC | 124/257 (48.2%) | 70/150 (46.7%) |
 | CC | 65/257 (25.3%) | 35/150 (23.3%) |
Allele Freq (C) | Â | 49.4% | 46.7% |
VEGF-634 | GG | 118/255 (46.3%) | 64/127 (50.4%) |
rs2010963 | GC | 118/255 (46.3%) | 45/127 (35.4%) |
 | CC | 19/255 (7.4%) | 18/127 (14.2%) |
Allele Freq (c) | Â | 30.6% | 31.9% |
FGF1 | CC | 110/242 (45.5%) | 74/154 (48.0%) |
rs34011 | CT | 108/242 (44.6%) | 64/154 (41.6%) |
 | TT | 24/242 (9.9%) | 16/154 (10.4%) |
Allele Freq (T) | Â | 32.2% | 31.2% |
FGF2 | CC | 167/254 (65.7%) | 99/154 (64.3%) |
rs1048201 | CT | 79/254 (31.1%) | 47/154 (30.5%) |
 | TT | 8/254 (3.2%) | 8/154 (5.2%) |
Allele Freq (T) | Â | 18.7% | 20.5% |
EGF | AA | 209/248 (84.3%) | 122/153 (79.7%) |
rs4444903 | GA | 4/248 (1.6%) | 1/153 (0.7%) |
 | GG | 35/248 (14.1%) | 30/153 (19.6%) |
Allele Freq (G) | Â | 14.9% | 19.9% |
EGF | GG | 78/256 (30.5%) | 55/154 (35.7%) |
rs2237051 | GA | 138/256 (53.9%) | 72/154 (46.8%) |
 | AA | 40/256 (15.6%) | 27/154 (17.5%) |
Allele Freq (A) | Â | 42.6% | 40.9% |
EGF | GG | 233/243 (95.9%) | 140/149 (94.0%) |
rs11568943 | GA | 10/243 (4.1%) | 9/149 (6.0%) |
 | AA | 0 | 0 |
Allele Freq (A) | Â | 2.1% | 3.0% |